Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer (vol 37, pg 2502, 2018)

被引:0
|
作者
Sirkisoon, Sherona R. [1 ]
Carpenter, Richard L. [1 ]
Rimkus, Tadas [1 ]
Anderson, Ashley [1 ]
Harrison, Alexandria [1 ]
Lange, Allison M. [1 ]
Jin, Guangxu [2 ]
Watabe, Kounosuke [1 ,3 ]
Lo, Hui-Wen [1 ,3 ]
机构
[1] Wake Forest Univ Sch Med, Dept Canc Biol, Winston Salem, NC 27104 USA
[2] Wake Forest Univ Sch Med, Dept Radiol, Winston Salem, NC USA
[3] Wake Forest Univ Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27157 USA
关键词
D O I
10.1038/s41388-024-03084-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:2371 / 2371
页数:1
相关论文
共 23 条
  • [1] Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
    Sherona R. Sirkisoon
    Richard L. Carpenter
    Tadas Rimkus
    Ashley Anderson
    Alexandria Harrison
    Allison M. Lange
    Guangxu Jin
    Kounosuke Watabe
    Hui-Wen Lo
    [J]. Oncogene, 2018, 37 : 2502 - 2514
  • [2] Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer
    Sirkisoon, Sherona R.
    Carpenter, Richard L.
    Rimkus, Tadas
    Anderson, Ashley
    Harrison, Alexandria
    Lange, Allison M.
    Jin, Guangxu
    Watabe, Kounosuke
    Lo, Hui-Wen
    [J]. ONCOGENE, 2018, 37 (19) : 2502 - 2514
  • [3] STAT3 and GLI1/tGLI1 oncogenic transcription factors interact to promote the aggressiveness of triple-negative and HER2-enriched breast cancers
    Sirkisoon, Sherona R.
    Carpenter, Richard L.
    Tadas, Rimkus
    Ashley, Anderson
    Harrison, Alexandria
    Lange, Allison M.
    Jin, Guangxu
    Watabe, Kounosuke
    Lo, Hui-Wen
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [4] TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers
    Regua, Angelina T.
    Aguayo, Noah R.
    Jalboush, Sara Abu
    Doheny, Daniel L.
    Manore, Sara G.
    Zhu, Dongqin
    Wong, Grace L.
    Arrigo, Austin
    Wagner, Calvin J.
    Yu, Yang
    Thomas, Alexandra
    Chan, Michael D.
    Ruiz, Jimmy
    Jin, Guangxu
    Strowd, Roy
    Sun, Peiqing
    Lin, Jiayuh
    Lo, Hui-Wen
    [J]. CANCERS, 2021, 13 (10)
  • [5] tGLI1 and IL-6/IL-6R/GP130/STAT3 pathways cooperate to promote breast cancer stem cells and are co-activated in HER2-enriched and triple-negative breast cancers
    Manore, Sara G.
    Doheny, Daniel L.
    Zhu, Dongqin
    Wong, Grace L.
    Regua, Angelina T.
    Arrigo, Austin
    Wagner, Calvin J.
    Najjar, Mariana
    Lo, Hui-Wen
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [6] TrkA and JAK2-STAT3 pathway crosstalk promotes breast cancer stem cells in HER2-enriched and triple-negative breast cancers
    Regua, Angelina T.
    Zhu, Dongqin
    Doheny, Daniel L.
    Wong, Grace L.
    Manore, Sara G.
    Wagner, Calvin J.
    Arrigo, Austin
    Najjar, Mariana
    Lo, Hui-Wen
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [7] ADGRF1 promotes tumorigenesis via the activation of STAT3 pathway in HER2+and triple-negative breast cancers
    Abdulkareem, Noor M.
    Bhat, Raksha
    Trivedi, Meghana V.
    [J]. FASEB JOURNAL, 2022, 36
  • [8] JAK2/STAT3 and TrkA pathways are frequently co-activated in triple-negative and HER2-enriched breast cancers and the co-activation correlates with an increased potential of metastasis.
    Regua, Angelina T.
    Aguayo, Noah R.
    Abu Jalboush, Sara
    Doheny, Daniel L.
    Manore, Sara G.
    Zhu, Dongqin
    Wong, Grace L.
    Arrigo, Austin
    Wagner, Calvin J.
    Yu, Yang
    Baylon, Karen
    Thomas, Alexandra
    Chan, Michael D.
    Ruiz, Jimmy
    Jin, Guangxu
    Strowd, Roy E.
    Sun, Peiqing
    Metheny-Barlow, Linda J.
    Lin, Jiayuh
    Lo, Hui-Wen
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [9] Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis (vol 39, pg 6589, 2020)
    Doheny, Daniel
    Sirkisoon, Sherona
    Carpenter, Richard L.
    Aguayo, Noah Reeve
    Regua, Angelina T.
    Anguelov, Marlyn
    Manore, Sara G.
    Arrigo, Austin
    Jalboush, Sara Abu
    Wong, Grace L.
    Yu, Yang
    Wagner, Calvin J.
    Chan, Michael
    Ruiz, Jimmy
    Thomas, Alexandra
    Strowd, Roy
    Lin, Jiayuh
    Lo, Hui-Wen
    [J]. ONCOGENE, 2024, 43 (23) : 1811 - 1811
  • [10] XPO1 ( CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
    Cheng, Yan
    Holloway, Michael P.
    Kevin Nguyen
    McCauley, Dilara
    Landesman, Yosef
    Kauffman, Michael G.
    Shacham, Sharon
    Altura, Rachel A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (03) : 675 - 686